These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 11160455)

  • 41. Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.
    Hagelberg N; Kajander JK; Någren K; Hinkka S; Hietala J; Scheinin H
    Synapse; 2002 Jul; 45(1):25-30. PubMed ID: 12112410
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.
    Ginovart N; Farde L; Halldin C; Swahn CG
    Synapse; 1997 Apr; 25(4):321-5. PubMed ID: 9097390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Imaging endogenous dopamine competition with [11C]raclopride in the human brain.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Schlyer D; Hitzemann R; Lieberman J; Angrist B; Pappas N; MacGregor R
    Synapse; 1994 Apr; 16(4):255-62. PubMed ID: 8059335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of four dopaminergic tracers kinetics using two different tissue input function methods.
    Sossi V; Holden JE; Chan G; Krzywinski M; Stoessl AJ; Ruth TJ
    J Cereb Blood Flow Metab; 2000 Apr; 20(4):653-60. PubMed ID: 10779009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. D1 and D2 specific dopamine antagonist modulate the caudate nucleus neuronal responses to chronic methylphenidate exposure.
    Venkataraman S; Claussen C; Dafny N
    J Neural Transm (Vienna); 2017 Feb; 124(2):159-170. PubMed ID: 27853928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR; Kuszpit K; Sherman P
    Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans.
    Volkow ND; Fowler JS; Wang GJ
    J Psychopharmacol; 1999 Dec; 13(4):337-45. PubMed ID: 10667609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The influence of tomograph sensitivity on kinetic parameter estimation in positron emission tomography imaging studies of the rat brain.
    Meikle SR; Eberl S; Fulton RR; Kassiou M; Fulham MJ
    Nucl Med Biol; 2000 Aug; 27(6):617-25. PubMed ID: 11056379
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.
    Volkow ND; Wang GJ; Fowler JS; Ding YS
    Biol Psychiatry; 2005 Jun; 57(11):1410-5. PubMed ID: 15950015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain.
    Rosa-Neto P; Gjedde A; Olsen AK; Jensen SB; Munk OL; Watanabe H; Cumming P
    Synapse; 2004 Sep; 53(4):222-33. PubMed ID: 15266554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationship between psychostimulant-induced "high" and dopamine transporter occupancy.
    Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Ding YS; Logan J; Dewey SL; Hitzemann R; Lieberman J
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10388-92. PubMed ID: 8816810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans.
    Cervenka S; Varrone A; Fransén E; Halldin C; Farde L
    Synapse; 2010 Jun; 64(6):478-85. PubMed ID: 20175222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters.
    Scheffel U; Steinert C; Kim SE; Ehlers MD; Boja JW; Kuhar MJ
    Synapse; 1996 Jun; 23(2):61-9. PubMed ID: 8723710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high".
    Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Logan J; Ding YS; Dewey SL; Hitzemann R; Gifford AN; Pappas NR
    J Pharmacol Exp Ther; 1999 Jan; 288(1):14-20. PubMed ID: 9862747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitation of dopamine transporter blockade by methylphenidate: first in vivo investigation using [123I]FP-CIT and a dedicated small animal SPECT.
    Nikolaus S; Wirrwar A; Antke C; Arkian S; Schramm N; Müller HW; Larisch R
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):308-13. PubMed ID: 15791440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans.
    Kegeles LS; Martinez D; Kochan LD; Hwang DR; Huang Y; Mawlawi O; Suckow RF; Van Heertum RL; Laruelle M
    Synapse; 2002 Jan; 43(1):19-29. PubMed ID: 11746730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nicotine modulates dopamine synthesis rate as determined by L-[beta-11C]DOPA: PET studies compared with [11C]raclopride binding in the conscious monkey brain.
    Tsukada H; Miyasato K; Harada N; Nishiyama S; Fukumoto D; Kakiuchi T
    Synapse; 2005 Aug; 57(2):120-2. PubMed ID: 15906385
    [No Abstract]   [Full Text] [Related]  

  • 59. Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity.
    Volkow ND; Wang GJ; Telang F; Fowler JS; Alexoff D; Logan J; Jayne M; Wong C; Tomasi D
    Proc Natl Acad Sci U S A; 2014 Jul; 111(30):E3149-56. PubMed ID: 25024177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
    Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.